Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

5 Stocks Under $10 Analysts Believe Could Soar 200%

by Global Market Bulletin
July 18, 2026
in Stock Market News
0
5 Stocks Under $10 Analysts Believe Could Soar 200%

5 Stocks Under $10 Analysts Believe Could Soar 200%

17
SHARES
38
VIEWS
Share on FacebookShare on Twitter

3. SharpLink Inc. (NASDAQ:SBET)

SharpLink Inc. (NASDAQ: SBET) ranks third among the 10 best stocks under $10 that could triple, with shares recently trading near $5.67 after declining 1.31%. Unlike the clinical-stage biotechnology companies dominating much of this list, SharpLink Inc. (NASDAQ: SBET) has developed a digital-asset treasury strategy centered on Ethereum.

You might also like

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

The company’s transformation into an institutional-grade Ethereum treasury platform has placed it among a growing group of publicly traded companies using digital assets as a major component of corporate capital allocation. Instead of holding only cash, government securities, or conventional investments, SharpLink Inc. (NASDAQ: SBET) is accumulating Ether and seeking to increase the amount of ETH represented by each outstanding common share.

On June 30, SharpLink Inc. (NASDAQ: SBET) announced that it had purchased an additional 10,000 Ether at an average price of approximately $1,611 per ETH. The acquisition increased its cumulative Ethereum holdings to 886,725 tokens.

At the referenced purchase price, the 10,000-token transaction represented a capital commitment of approximately $16.11 million. More important than the size of one purchase, however, is the company’s broader strategy of using corporate financing and balance-sheet resources to build a substantial position in Ethereum.

Ethereum is the blockchain network supporting the Ether cryptocurrency. It is widely used for decentralized finance applications, stablecoins, tokenization, digital ownership, smart contracts, and other blockchain-based activities. Supporters of Ethereum believe the network could become an important settlement and infrastructure layer for digital finance.

SharpLink Inc. (NASDAQ: SBET) is attempting to provide public-market investors with a way to obtain exposure to that ecosystem through ordinary shares. The stock’s value may therefore be influenced not only by the company’s operating business but also by the market value of its Ethereum treasury, the number of outstanding shares, and management’s ability to increase ETH holdings on a per-share basis.

The company also announced that it had repurchased more than 2.13 million common shares through open-market transactions at an average price of approximately $4.69 per share. The repurchases were completed under its existing stock-buyback program.

Share repurchases can reduce the number of outstanding shares, which may increase the amount of Ethereum attributable to each remaining share. In a conventional company, buybacks are often evaluated based on earnings per share. For SharpLink Inc. (NASDAQ: SBET), management appears more focused on ETH per share as a primary measure of capital-allocation effectiveness.

Chief Executive Officer Joseph Chalom discussed the company’s recently completed $75 million registered direct offering, saying the financing strengthened its balance sheet and supported its active Ethereum treasury-management strategy. He described the company’s approach as disciplined and focused on the long-term objective of increasing ETH per share.

This strategy requires careful execution. Raising new capital can give SharpLink Inc. (NASDAQ: SBET) additional funds to acquire Ethereum, but issuing more common shares also increases the denominator used in calculating ETH per share. A financing only creates per-share value when the assets acquired with the new funds outweigh the dilutive effect of the additional shares and associated warrants.

Earlier, on June 22, SharpLink Inc. (NASDAQ: SBET) announced that it had entered into a securities purchase agreement with an institutional investor. The transaction covered the sale of more than 10 million common shares along with warrants permitting the purchase of additional shares.

The combined purchase price was $7.49 for each share and accompanying warrant. According to the company, this represented a premium of approximately 41% over the prevailing market price at the time of the agreement.

Selling securities at a premium can be viewed more favorably than completing a deeply discounted financing because it may reduce the immediate dilution imposed on existing shareholders. The attached warrants, however, still create the possibility of additional shares entering the market if they are exercised.

The financing strategy highlights the unusual nature of the investment case. SharpLink Inc. (NASDAQ: SBET) is effectively using the public equity markets to build an Ethereum treasury while attempting to manage dilution through capital raises, asset purchases, share repurchases, and other transactions.

Investors evaluating SharpLink Inc. (NASDAQ: SBET) must therefore look beyond the absolute number of ETH held by the company. The more relevant questions involve the amount of Ethereum per diluted share, the company’s market capitalization relative to the value of its treasury, its debt and warrant obligations, and its ability to generate additional yield or operating income without introducing excessive risk.

A digital-asset treasury company can trade above or below the net value of its cryptocurrency holdings. When investor sentiment is strong, the stock may command a premium because shareholders expect management to continue increasing digital assets per share. During periods of weak sentiment, the same company may trade at a discount because investors are concerned about volatility, dilution, governance, or the sustainability of the strategy.

SharpLink Inc. (NASDAQ: SBET) is also exposed to substantial cryptocurrency-market risk. Ether prices can rise or fall rapidly in response to regulatory decisions, technological developments, institutional adoption, liquidity conditions, macroeconomic factors, security incidents, or changes in investor sentiment.

A major decline in the price of Ether would reduce the value of the company’s treasury and could place pressure on the stock. Conversely, a sustained Ethereum rally could significantly increase the company’s asset value, especially if management succeeds in growing ETH holdings faster than its diluted share count.

The company continues to operate its original performance-based customer-acquisition business serving sportsbook and online casino operators. It helps licensed gaming companies generate user traffic and acquire players through PAS.net and a portfolio of digital properties focused on specific U.S. states.

This operating segment provides SharpLink Inc. (NASDAQ: SBET) with a business outside its cryptocurrency treasury, but the market’s attention is increasingly centered on Ethereum. The company’s valuation may therefore behave more like a leveraged digital-asset proxy than a traditional marketing or gaming-services stock.

Investors searching for Ethereum stocks, crypto treasury stocks under $10, high-growth blockchain stocks, and speculative digital-asset stocks could find SharpLink Inc. (NASDAQ: SBET) compelling. It offers potentially amplified exposure to Ethereum, particularly when the stock trades at a valuation close to or below the underlying treasury value.

That amplification works in both directions. SharpLink Inc. (NASDAQ: SBET) could rise dramatically if Ether appreciates, institutional demand increases, and management grows ETH per share. It could also fall sharply if cryptocurrency prices weaken or financing activity produces more dilution than value.

Among the best stocks under $10 that could triple, SharpLink Inc. (NASDAQ: SBET) stands out as one of the most unconventional. The company is not relying on an FDA decision or a new oil field. Its future is tied to Ethereum, public-market capital allocation, and management’s ability to demonstrate that an actively managed digital-asset treasury can create lasting value for shareholders.

Click next to see the following stock...

Page 3 of 5
Prev12345Next
Tags: 5 Stocks Under $10 Analysts Believe Could Soar 200%ARS Pharmaceuticals Inc. (NASDAQ:SPRY)Daily NewsletterHeadlineLexeo Therapeutics Inc. (NASDAQ:LXEO)NASDAQ:LXEONASDAQ:OMERNASDAQ:SBETNASDAQ:SGMTNASDAQ:SPRYOmeros Corp. (NASDAQ:OMER)Sagimet Biosciences Inc. (NASDAQ:SGMT)SharpLink Inc. (NASDAQ:SBET)Yahoo Finance
Share7Tweet4

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

by Global Market Bulletin
July 18, 2026
0
Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

by Global Market Bulletin
July 18, 2026
0
Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

by Global Market Bulletin
July 18, 2026
0
What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?
  • Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?
  • Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?